Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bradycardia Prevention
Research on bradycardia prevention described by scientists at Sunnybrook Health Science Center
April 19th, 2008
Researchers detail in 'A randomized controlled feasibility trial comparing safety and effectiveness of prehospital pacing versus conventional treatment: 'PrePACE',' new data in bradycardia. "To evaluate the feasibility of a prehospital randomized controlled trial comparing transcutaneous pacing (TCP) with dopamine for unstable bradycardia. Unstable bradycardic patients who failed to respond to a fluid bolus and up to 3mg atropine were enrolled," scientists writing in the journal Resuscitation report. "The intervention was dopamine or TCP with crossover to dopamine if TCP failed. The primary outcome was survival to discharge or 30 days. Randomization compliance,...
Source: Law & Health Weekly (2008-04-19)
|
